A method for the preparation of a non-glycosylated human recombinant human IL-2

摘要

The invention relates to a nonglycosylated, recombinant human IL2 in which the three cysteines in positions 58, 105 and 125 are in the reduced form and which exhibits a biological activity comparable with that of the oxidised IL2 having the same sequence and containing a disulphide bridge in position 58-105, to the process for obtaining it and to its application as a medication.